An AI tool accurately detected structural heart disease from smartwatch single-lead ECGs in a 600-person prospective trial.
Key Details
- 1AI model was trained using 266,000 12-lead ECGs from 110,000 patients and validated on large external cohorts.
- 2Prospective real-world testing was performed with 600 adults using smartwatch-recorded single-lead ECGs.
- 3Algorithm achieved 88% accuracy (AUC) in smartwatch data; sensitivity was 86% and negative predictive value 99%.
- 4Diseases detected included weakened pumping, valve damage, or thickened heart muscle—most commonly found with cardiac ultrasound (echo).
- 5Preliminary results were presented at AHA Scientific Sessions 2025 and have not yet been peer-reviewed.
Why It Matters
Wearable devices leveraging AI may democratize early detection of serious heart conditions, traditionally requiring advanced imaging. This signals a potential paradigm shift in accessible screening workflows, informing radiology and cardiology practice.
Source
EurekAlert
Related News
•EurekAlert
AI Accelerates Radiopharmaceuticals, Boosts Personalized Dosimetry in Cancer
Machine learning is driving advancements in radiopharmaceutical drug discovery and optimizing patient-specific dosimetry for precision cancer therapy.
•EurekAlert
Physicians Overly Trust Erroneous AI, Ignore Contradictory Evidence
Physicians tend to trust incorrect AI advice, even when evidence contradicts it, suggesting risks in clinical decision-making with AI tools.
•EurekAlert
Concerns Raised Over Unverified Datasets in AI Health Prediction Models
A new study finds widely used AI health prediction models are built on datasets with unverifiable origins, raising safety and validity concerns.